GENE EDITING INSTITUTE

Launched at ChristianaCare in 2015 under the leadership of gene editing pioneer Eric Kmiec, Ph.D., the Gene Editing Institute is a world leader in CRISPR gene editing technology. It is the only institute of its kind embedded in a community health system and brings a unique patient focus to the cutting-edge science of CRISPR gene editing. As a wholly owned subsidiary of ChristianaCare, the Institute is positioned to fast-track new research discoveries to patients... The Gene Editing Institute is leading the world in patient-first genomic science for the advancement of disease therapy to improve human health... The Gene Editing Institute explores the potential of CRISPR-directed gene editing for application in oncology and inherited disease. We focus on bringing innovative research from bench to bedside by using CRISPR-directed gene editing to mitigate the failure of standard cancer care. Our education and outreach program aims to demystify gene editing technology while enriching STEM..